The presence of bone marrow fibrosis is associated with poorer prognosis in newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Paul, B; Loitsch, G; Feinberg, D; Barak, I; Li, Z; Wang, E; Zhao, Y; Dupuis, M; Kang, Y

Published Date

  • May 20, 2019

Published In

Volume / Issue

  • 37 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2019

Conference End Date

  • June 4, 2019